
Carvista6.25 mg
Incepta Pharmaceuticals Ltd.
Carvedilol is indicated for the following conditions, with evidence strength noted for each: Chronic heart failure (mild to severe), established/FDA-approved: Carvedilol is used and more.
Carvedilol is indicated for the following conditions, with evidence strength noted for each:
Carvedilol should always be used exactly as prescribed by a physician, and any change in dose or indication should be made only under medical supervision.
| Indication | Adult Starting Dose | Titration | Maximum Dose |
|---|---|---|---|
| Chronic Heart Failure | 3.125 mg twice daily | Double the dose every 2 weeks as tolerated (6.25 mg, then 12.5 mg, then 25 mg twice daily) | 25 mg twice daily (body weight <85 kg) or 50 mg twice daily (body weight ≥85 kg) |
| LV Dysfunction after Heart Attack | 6.25 mg twice daily | Increase to 12.5 mg then 25 mg twice daily over 3-10 days, as tolerated | 25 mg twice daily |
| Hypertension | 6.25 mg twice daily (or 12.5 mg once daily per some regional labeling) | Increase at intervals of 1-2 weeks as needed | 50 mg per day (in divided doses) |
All doses of Carvedilol should be taken with food to slow the rate of absorption and reduce the risk of orthostatic hypotension and dizziness. Tablets should be swallowed whole with water; they should not be crushed or chewed unless the specific formulation permits it. Blood pressure, heart rate, and clinical status (signs of worsening heart failure or excessive bradycardia/hypotension) should be checked before each dose increase. Carvedilol must never be stopped abruptly — see Precautions and Warnings for details.
Side effects of Carvedilol vary somewhat by indication but commonly include:
Patients should seek prompt medical attention for fainting, very slow heart rate, severe dizziness, difficulty breathing, chest pain, signs of liver problems (yellowing of the skin/eyes, dark urine), or any signs of a severe allergic or skin reaction while taking Carvedilol.
Carvedilol is contraindicated (must not be used) in patients with any of the following conditions:
Carvedilol should only be used in these settings, or in patients with other significant cardiac or hepatic disease, if a physician has explicitly determined the benefit outweighs the risk.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.